Switch to:
GuruFocus has detected 7 Warning Signs with PDL BioPharma Inc $PDLI.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
PDL BioPharma Inc (NAS:PDLI)
EV-to-Revenue
1.28 (As of Today)

EV/Revenue ratio is calculated as enterprise value divided by its revenue. As of today, PDL BioPharma Inc's enterprise value is $238.9 Mil. PDL BioPharma Inc's revenue for the trailing twelve months (TTM) ended in Mar. 2017 was $186.6 Mil. Therefore, PDL BioPharma Inc's EV/Revenue ratio for today is 1.28.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today, PDL BioPharma Inc's stock price is $2.54. PDL BioPharma Inc's revenue per share for the trailing twelve months (TTM) ended in Mar. 2017 was $1.14. Therefore, PDL BioPharma Inc's P/S Ratio for today is 2.24.


Definition

EV/Revenue is a similar ratio to P/S Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

PDL BioPharma Inc's EV/Revenue for today is calculated as:

EV/Revenue=Enterprise Value (Today)/Revenue (TTM)
=238.933/186.617
=1.28

PDL BioPharma Inc's current Enterprise Value is $238.9 Mil.
PDL BioPharma Inc's Revenue for the trailing twelve months (TTM) ended in Mar. 2017 was 21.047 (Jun. 2016 ) + 53.638 (Sep. 2016 ) + 66.492 (Dec. 2016 ) + 45.44 (Mar. 2017 ) = $186.6 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

PDL BioPharma Inc's P/S Ratio for today is calculated as:

P/S Ratio=Share Price (Today)/Revenue Per Share (TTM)
=2.54/1.135
=2.24

PDL BioPharma Inc's share price for today is $2.54.
PDL BioPharma Inc's Revenue Per Share for the trailing twelve months (TTM) ended in Mar. 2017 was 0.128 (Jun. 2016 ) + 0.326 (Sep. 2016 ) + 0.404 (Dec. 2016 ) + 0.277 (Mar. 2017 ) = $1.14.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Related Terms

Enterprise Value, Revenue, P/S Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

PDL BioPharma Inc Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
ev2rev 9.033.723.913.302.943.013.262.421.041.41

PDL BioPharma Inc Quarterly Data

Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17
ev2rev 2.422.131.951.751.040.901.491.701.411.08
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK